BioAge Labs (BIOA) Common Equity (2023 - 2026)
BioAge Labs (BIOA) posted Common Equity of $379.1 million for Q1 2026, up 39.36% sequentially from $272.1 million in Q4 2025, and up 21.06% YoY from $313.2 million in Q1 2025.
BioAge Labs (BIOA) Common Equity (2023 - 2026) Analysis & Trends
BioAge Labs has reported Common Equity for 4 years, with the latest figure at $379.1 million in Q1 2026.
- Quarterly Common Equity rose 21.06% year-over-year to $379.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $379.1 million (up 21.06% YoY) and the FY2025 annual result came in at $272.1 million, down 15.81% from the prior year.
- Common Equity grew to $379.1 million in Q1 2026 per BIOA's latest filing, from $272.1 million in the prior quarter.
- Over five years, Common Equity peaked at $379.1 million in Q1 2026 and troughed at -$197.1 million in Q2 2024.
- A 4-year average of $133.1 million and a median of $277.5 million in 2025 frame the typical range for Common Equity.
- The sharpest annual moves came in 2024 and 2025: Common Equity soared 304.88% in 2024, then slipped 15.81% in 2025.
- Over 4 years, Common Equity stood at -$173.4 million in 2023, then surged by 286.35% to $323.1 million in 2024, then dropped by 15.81% to $272.1 million in 2025, then surged by 39.36% to $379.1 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $379.1 million, $272.1 million, and $277.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | BioAge Labs | 437.18 Mn | 437.18 Mn | -14.23 Mn | 374.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 374.91 Mn |
| Mar 31, 2026 | 379.12 Mn |
| Dec 31, 2025 | 272.05 Mn |
| Sep 30, 2025 | 277.46 Mn |
| Jun 30, 2025 | 294.78 Mn |
| Mar 31, 2025 | 313.17 Mn |
| Dec 31, 2024 | 323.13 Mn |
| Sep 30, 2024 | 313.75 Mn |
| Jun 30, 2024 | -197.13 Mn |
| Mar 31, 2024 | -185.51 Mn |
| Dec 31, 2023 | -173.40 Mn |
| Sep 30, 2023 | -153.14 Mn |